Detalhe da pesquisa
1.
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.
Hepatology
; 61(4): 1127-35, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25614962
2.
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir.
Liver Int
; 36(11): 1611-1618, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27188960
3.
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial.
Open Forum Infect Dis
; 11(4): ofae140, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38595956
4.
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
Lancet Infect Dis
; 23(9): 1072-1084, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37182534
5.
Acute Adverse Effects of Vaccines Against SARS-COV-2.
Cureus
; 14(7): e27379, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36046318
6.
COVID-19 pandemic and antimicrobial resistance in developing countries.
Discoveries (Craiova)
; 9(2): e127, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34754900
7.
Correlation Between Peak Expiratory Flow Rate, Markers of Adiposity, and Anthropometric Measures in Medical Students in Pakistan.
Cureus
; 12(12): e12408, 2020 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33537180
8.
Is COVID-19 Fatality Rate Associated with Malaria Endemicity?
Discoveries (Craiova)
; 8(4): e120, 2020 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33365386
9.
Role of Interleukin-10 and Abdominopelvic Ultrasound as a Potential Predictor of Disease Severity in Dengue Hemorrhagic Fever.
Cureus
; 11(7): e5249, 2019 Jul 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31572634
10.
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
PLoS One
; 11(10): e0164563, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27749900